Retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously, compared to semaglutide (GLP-1 only) and tirzepatide (GLP-1 and GIP)
Winter freezing risks Cold weather introduces the opposite problem
Observations of thyroid C-cell tumors in rodent studies have triggered discussions about potential long-term human risks
10.1007/s11892-024-01537-3 61 PrajapatiA.RanaD.RangraS.JindalA
When injections first are administered, a patient with severe symptoms may receive five to seven during the first week to restore the body's reserves of this nutrient
Generalized linear mixed effects models were used to compare the low carnitine status with the normal carnitine status on percent change from previous timepoint in seizure frequency, seizure severity, BHB level, number of side effects, fasting triglyceride, weight and BMI, where identity links were used for normally distributed outcome